Company intelligence / Profile preview
Vedana Therapeutics
Woodinville, Washington, United Statesvedanatx.com ↗
- Ownership
- Private
- Employees
- ~14
- Development stage
- Other
01
Overview
Vedana Therapeutics is a private biotechnology company developing next-generation preventive therapies for migraine. The company emerged from stealth in June 2026 with a $46 million Series A financing and is focused on long-acting, subcutaneously delivered antibody medicines aimed at clinically validated migraine pathways beyond first-generation CGRP approaches. Its lead pipeline includes an anti-PACAP monoclonal antibody and a bispecific PACAP x CGRP antibody, both intended for at-home self-injection and improved migraine control. Vedana is led by executives and advisors with prior experience developing major migraine biologics, including CGRP- and PACAP-directed programs.
- Therapeutic areas
- Neurology
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyAntibody
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Vedana Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vedana Therapeutics.